LivaNova plc Stock
Price
Target price
€48.00
€48.00
-2.830%
-1.4
-2.830%
€64.66
18.04.24 / Frankfurt
WKN: A14156 / Symbol: LIVN / Name: LivaNova / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
LivaNova plc Stock
A loss of -2.830% shows a downward development for LivaNova plc.
LivaNova plc is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 64 € there is a positive potential of 33.33% for LivaNova plc compared to the current price of 48.0 €.
Pros and Cons of LivaNova plc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | -2.830% | -4.950% | 4.803% | 11.111% | 2.564% | -29.927% | -18.644% |
| Neogen Corp. | -0.890% | -1.754% | -18.841% | -24.324% | -38.798% | -71.282% | -53.819% |
| Bio-Rad Labs Inc. A | -3.080% | -9.116% | -13.941% | -40.064% | -10.014% | -49.676% | - |
| Merit Medical Systems | -1.490% | -3.650% | 1.538% | -4.348% | -2.941% | 30.693% | 29.159% |
Comments
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $75.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Needham & Company LLC from $62.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
News
LivaNova to Announce First-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (the